SEOM clinical guidelines in early stage breast cancer (2018)

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Ayala de la Peña, F.
  • dc.contributor.author Andrés, Raquel
  • dc.contributor.author Garcia-Saenz, José Angel
  • dc.contributor.author Manso, Luis
  • dc.contributor.author Margeli, M. E.
  • dc.contributor.author Dalmau, M. E.
  • dc.contributor.author Pernas, S.
  • dc.contributor.author Prat, Aleix
  • dc.contributor.author Servitja Tormo, Sonia
  • dc.contributor.author Ciruelos, Eva
  • dc.date.accessioned 2019-03-27T08:44:41Z
  • dc.date.available 2019-03-27T08:44:41Z
  • dc.date.issued 2019
  • dc.description.abstract Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20-30% of patients will relapse despite appropriate locoregional and systemic therapies. A better knowledge of this disease is improving our ability to select the most appropriate therapy for each patient with a recent diagnosis of an early stage breast cancer, minimizing unnecessary toxicities and improving long-term efficacy.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Ayala de la Peña F, Andrés R, Garcia-Sáenz JA, Manso L, Margelí M, Dalmau E. et al. SEOM clinical guidelines in early stage breast cancer (2018). Clin Transl Oncol. 2019 Jan;21(1):18-30. DOI: 10.1007/s12094-018-1973-6
  • dc.identifier.doi http://dx.doi.org/10.1007/s12094-018-1973-6
  • dc.identifier.issn 1699-048X
  • dc.identifier.uri http://hdl.handle.net/10230/36977
  • dc.language.iso eng
  • dc.publisher SpringerOpen
  • dc.relation.ispartof Clinical and Translational Oncology. 2019 Jan;21(1):18-30
  • dc.rights This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creative commons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creative commons.org/licenses/by/4.0/
  • dc.subject.keyword Early breast cancer
  • dc.subject.keyword Adjuvant
  • dc.subject.keyword Follow-up
  • dc.subject.keyword Genomic predictive test
  • dc.subject.keyword Neoadjuvant
  • dc.subject.other Mama -- Càncer
  • dc.title SEOM clinical guidelines in early stage breast cancer (2018)
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion